cdmo.directory
← Compare landing

Enable Biotech Ltd vs Hillgene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/enablebiotech/hillgene

CategoryEnable Biotech LtdHillgene
Listed sitecdmocdmo
SummaryEnable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024.Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
Services
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
  • mRNA
  • Gene Therapy
IndicationsData not yet provided.
  • Oncology
  • Immunology
Locations
  • Headquarters, Zug, Switzerland
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
CertificationsData not yet provided.
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.